We are Sorry, This Page doesn't Exist
Bristol-Myers says late-stage trial of treatment for multiple myeloma missed main goal
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Bristol-Myers Squibb Gains Europe"s Approval for Empliciti
The drug treats multiple myelomaRelated Stocks: BMY, CELG,.....»»
Abbvie To Buy Allergan For $60 Billion In Latest Pharma Megadeal
Just months after Bristol-Myers Squibb and Celgene announced one of the biggest drug industry tie-ups in recent memory.....»»
Your Cancer Research Highlight: Bristol-Myers Looks For An In To Earlier Multiple Myeloma
Your Cancer Research Highlight: Bristol-Myers Looks For An In To Earlier Multiple Myeloma.....»»
Bristol Myers Squibb stock falls, as profit and revenue rise but miss expectations
Shares of Bristol Myers Squibb Co. shed 2.1% in premarket trading Thursday, after the drug maker reported a first-quarter profit that came up short of expe.....»»
Eli Lilly Rated Top in Innovation, Bristol-Myers Leader in Invention
IDEA Pharma rates drug companies in both categoriesRelated Stocks: LLY, BMY, RHHBY, AMGN, TEVA, REGN, SEGN, INCY, GSK, SNY, AZN,.....»»
Citi sees "material upside" for AbbVie, Bristol-Myers after Pfizer data
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bluebird, Bristol-Myers Squibb have resubmit FDA bid for CAR-T therapy
Shares of Bluebird Bio Inc. declined 5.9% in premarket trading on Wednesday after the company and Bristol-Myers Squibb Co. said the Food and Drug Administr.....»»
Drug makers on shaky ground as clinical trials are postponed and drug launches delayed amid pandemic
Bristol-Myers Squibb Co.’s decisi.....»»
Why Bristol-Myers Squibb"s Stock is Trading Higher Today
Bristol-Myers Squibb Company (NYSE: BMY) shares are trading higher after the company announced the FDA has approved ZEPOSIA, its new oral treatment for relapsing forms of multiple sclerosis. read more.....»»
China suspends Bristol-Myers" cancer drug sales over findings at U.S. plant
Sales of Bristol-Myers Squibb Co's cancer drug Abraxane have been suspended in China based on findings at a third-party manufacturing plant in the United States......»»
China suspends Bristol-Myers" cancer drug over findings at U.S. plant
China has suspended sale, import and use of Bristol-Myers Squibb Co's cancer drug, Abraxane, the U.S. drugmaker's China marketing partner said on Wednesday......»»
Cramer"s lightning round: Swap Pfizer for Bristol-Myers or Abbvie
"Mad Money" host Jim Cramer makes buy and sell calls on Pfizer, Nextera Energy, Axon Enterprise and more stocks......»»
Bristol-Myers announces data from multiple liso-cel studies at ASH meeting
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers stock slides premarket after melanoma trial fails to meet main goal
Bristol-Myers Squibb Co. shares slid 0.9% in premarket trade Wednesday, after the drug company said a trial of opdivo p.....»»
Bristol-Myers Squibb wins antitrust approval to buy Celgene, but must divest psoriasis drug
Bristol-Myers Squibb Co and Celgene Corp have won U.S. antitrust approval for their merger on condition that they sell Celgene's psoriasis drug Otezla, the Federal Trade Commission said in a statement on Friday......»»
Bristol-Myers tops earnings estimates but lowers guidance
Bristol-Myers Squibb Co. shares rose 0.9% after the company beat earnings estimates but lowered its full-year per-share earnings guidance. The New York-based drug company said it had net income of $1.353 billion,.....»»
AbbVie, Bristol-Myers Squibb Getting the Most From Workers
Pharmaceutical companies that top the list in terms of sales per employeeRelated Stocks: ABBV, BMY, SNY, AZN, CELG, XPH,.....»»
Everything Jim Cramer said on "Mad Money," including the week ahead, iPhone sales, Zscaler CEO
Jim Cramer previews the week ahead of earnings and stock market news, projects iPhone sales in China, breaks down AbbVie and Bristol-Myers' latest deals and interviews Zscaler CEO Jay Chaudhry......»»